InvestorsHub Logo
Followers 11
Posts 822
Boards Moderated 0
Alias Born 07/24/2015

Re: None

Wednesday, 12/09/2015 4:43:22 PM

Wednesday, December 09, 2015 4:43:22 PM

Post# of 27649
Imo;
It appears as if development has reached a technical hurdle either with the FAIMS calibration (+/-80%) or with the miniaturization of certain components, or both. Realistically, it is a developing technology, and technical issues are to be expected (hence the reasons for prototypes). Perhaps management should refocus on the engineering element with the task at hand, instead of an IPO.

Regarding Breathtec- I also agree. Not a cent until we see positive test results from a BETA prototype.

PS- Shell, I was also under the impression our options agreement with UFL expires in January. I searched for specifics on the agreement and couldn't find anything. Does anyone have a link?

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News